Farinotti R - Search Results

1

Effect on gastric secretion, gastrin and histamine release during and after long-term treatment by pirenzepine in dogs.

Vatier J, Riquet W, Célice-Pingaud C, Olivier A, Mignon M, Farinotti R. Vatier J, et al. Among authors: farinotti r. Fundam Clin Pharmacol. 1996;10(2):144-50. doi: 10.1111/j.1472-8206.1996.tb00157.x. Fundam Clin Pharmacol. 1996. PMID: 8737957

2

Interests of the 'artificial stomach' techniques to study antacid formulations: comparison with in vivo evaluation.

Vatier J, Célice-Pingaud C, Farinotti R. Vatier J, et al. Among authors: farinotti r. Fundam Clin Pharmacol. 1998;12(6):573-83. doi: 10.1111/j.1472-8206.1998.tb00989.x. Fundam Clin Pharmacol. 1998. PMID: 9818289 Review.

3

In vitro assessment of antacid efficacy using a computer-controlled 'artificial stomach-duodenum' model reproducing gastroduodenal flux regulation.

Vatier J, Cai S, Célice-Pingaud C, Castela-Papin N, Mignon M, Farinotti R. Vatier J, et al. Among authors: farinotti r. Therapie. 1996 Mar-Apr;51(2):147-54. Therapie. 1996. PMID: 8763049

4

[Antacid activity of citrate-bicarbonate complex of effervescent formulations of ranitidine. In vitro analysis using 'artificial stomach-duodenum' model].

Vatier J, Cai S, Slama A, Farinotti R. Vatier J, et al. Among authors: farinotti r. Therapie. 1996 Mar-Apr;51(2):139-46. Therapie. 1996. PMID: 8763048 French.

5

Drug interactions with diosmectite: a study using the artificial stomach-duodenum model.

Castela-Papin N, Cai S, Vatier J, Keller F, Souleau CH, Farinotti R. Castela-Papin N, et al. Among authors: farinotti r. Int J Pharm. 1999 May 10;182(1):111-9. doi: 10.1016/s0378-5173(99)00073-3. Int J Pharm. 1999. PMID: 10332080

6

Interactions of cimetidine and ranitidine with aluminum-containing antacids and a clay-containing gastric-protective drug in an "artificial stomach-duodenum" model.

Vatier J, Harman A, Castela N, Droy-Lefaix MT, Farinotti R. Vatier J, et al. Among authors: farinotti r. J Pharm Sci. 1994 Jul;83(7):962-6. doi: 10.1002/jps.2600830709. J Pharm Sci. 1994. PMID: 7965675

7

[Treatment of hemorrhagic rectocolitis with 5-aminosalicylic acid enema].

Benedittini N, Farinotti R, Rene E, Likforman J, Dauphin A, Mignon M. Benedittini N, et al. Among authors: farinotti r. Presse Med. 1985 Mar 30;14(13):748. Presse Med. 1985. PMID: 3157983 French. No abstract available.

8

Cetuximab increases concentrations of irinotecan and of its active metabolite SN-38 in plasma and tumour of human colorectal carcinoma-bearing mice.

Chu C, Abbara C, Tandia M, Polrot M, Gonin P, Farinotti R, Bonhomme-Faivre L. Chu C, et al. Among authors: farinotti r. Fundam Clin Pharmacol. 2014 Dec;28(6):652-60. doi: 10.1111/fcp.12071. Epub 2014 Apr 16. Fundam Clin Pharmacol. 2014. PMID: 24588516

9

[5-Aminosalicylic acid enema preparation].

René E, Farinotti R, Mignon M, Cerf M, Dauphin A, Bonfils S. René E, et al. Among authors: farinotti r. Gastroenterol Clin Biol. 1983 Nov;7(11):935. Gastroenterol Clin Biol. 1983. PMID: 6653982 French. No abstract available.

10

Effect of hr-IL2 treatment on intestinal P-glycoprotein expression and activity in Caco-2 cells.

Belliard AM, Tardivel S, Farinotti R, Lacour B, Leroy C. Belliard AM, et al. Among authors: farinotti r. J Pharm Pharmacol. 2002 Aug;54(8):1103-9. doi: 10.1211/002235702320266262. J Pharm Pharmacol. 2002. PMID: 12195825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

266 results

Search Page

Filters